Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHANOS (Physostigmine-enhanced Opioid Analgesia) Study
2012-000130-19Phase 3Completed
- Sponsor
- Medical University of Graz
- Start
- Jul 2012
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of physostigmine in postoperative pain (2 arms), sponsored by Medical University of Graz. Primary endpoint: opioid requirement. Started Jul 2012; status: completed.
02
Drugs
physostigmine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2012-000130-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000130-19.